Enjoy complimentary customisation on priority with our Enterprise License!
The biodefense market share is expected to increase by USD 5.40 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 7.08%.
This biodefense market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers biodefense market segmentations by application (anthrax, smallpox, botulism, and others) and geography (North America, Europe, Asia, and ROW). The biodefense market report also offers information on several market vendors, including Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc among others.
Download the Free Report Sample to Unlock the Biodefense Market Size for the Forecast Period and Other Important Statistics
Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The rising prevalence of infectious diseases is notably driving the biodefense market growth, although factors such as lack of information about bioengineered organisms attack may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the biodefense industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Biodefense Market Driver
One of the key factors driving the biodefense market growth is the rising prevalence of infectious diseases. Infectious diseases are caused by pathogens and can be transmitted from one person to another through direct or indirect contact. Thus, factors that favor the growth and transmission of these pathogens contribute to the spread of infectious diseases. Demographic changes caused by increased globalization and urbanization are major factors leading to the global emergence of infectious diseases. Urbanization has led to the overcrowding of human inhabitants. High population densities in these areas favor the colonization of disease pathogens and their persistence in human populations. The growing number of dams, poor living conditions, lack of sanitation, and inadequate waste management systems are some of the other factors that have increased the incidence and prevalence of diseases. In addition, the changes in environmental conditions and the growing trade and travel are contributing to the increase in the occurrence of infectious diseases among people. Hence, the need for preventive measures drives the growth of the global biodefense market.
Key Biodefense Market Trend
Government initiatives is the major trend influencing the biodefense market growth. Biological agents are easy to obtain, as these are naturally present in the environment. The possibility of developing novel weapons through the use of these agents is alarming. Laboratories across the world are working on the development of advanced detection systems to identify areas and populations at risk of bioterrorism, provide early warning, and facilitate prompt treatment. Forensic technologies in many countries such as the US are working on identifying biological agents, their environmental origins, and their initial sources. Efforts include sanitization technologies to reinstate facilities without causing any additional concerns. Early detection and quick response to bioterrorism depend on the cooperation between law enforcement and public health authorities, and the steps mentioned above confirm the required response is taken to minimize the effect due to any bioterrorism activities.
Key Biodefense Market Challenge
Lack of information about bioengineered organisms attack is one of the key challenges hindering the biodefense market growth. Genetically altered organisms are widely used in scientific studies and have facilitated the development of new medical therapies, preventive strategies, and diagnostic tools. However, such organisms can be maliciously used in applications such as bioterrorism. Intentional or accidental transmission to humans can lead to adverse health effects. However, the unique microbial properties of genetically engineered organisms and the clinical symptoms shown by persons infected with them may obstruct the normal diagnostics and clinical assessments or preventive approaches as the genetically modified strains are never field-tested. Hence, the actual virulence potential of these microbes remains unknown. Concerns about biotechnology being used to develop new pathogens with exclusive properties or to create completely new classes of biological threat agents are a huge challenge for the global biodefense market in the current scenario.
This biodefense market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Technavio categorizes the global biodefense market as a part of the global biotechnology market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the biodefense market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the biodefense market encompasses successful business strategies deployed by the key vendors. The biodefense market is fragmented and the vendors are deploying growth strategies such as mergers and acquisitions to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The biodefense market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the biodefense market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
For more insights on the market share of various regions Request for a FREE sample now!
48% of the market's growth will originate from North America during the forecast period. US is the key market for biodefense in North America. Market growth in this region will be faster than the growth of the market in other regions.
North America will continue to lead the market during the forecast period due to significant investments in the defense sector by the US. Instances of bioterrorism in the past and impending bioterrorism attacks propel the growth of the market. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the outbreak of COVID-19 limited the economic growth in the region. To mitigate the spread of the disease, lockdowns were imposed by the governments of various countries, such as the US, Canada, and Mexico, which restricted business activities in North America. This affected the supply chain of raw materials that are used for the manufacturing of biodefense products. However, the demand for biodefense products increased in 2020 due to health concerns among the people in North America. Hence, the regional market is expected to grow during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The biodefense market share growth by the anthrax will be significant during the forecast period. The use of anthrax as a bioweapon such as Amerithrax and the life-threatening potential of the bacteria propel the global biodefense against the anthrax market.
Besides the above-mentioned factors, the post COVID-19 impact has brought forth a slowdown in or fast tracked the demand for the service or product. This report provides an accurate prediction of the contribution of all the segments to the growth of the biodefense market size and actionable market insights on post COVID-19 impact on each segment.
Biodefense Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.08% |
Market growth 2021-2025 |
$ 5.40 billion |
Market structure |
Fragmented |
YoY growth (%) |
6.12 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 48% |
Key consumer countries |
US, UK, Japan, Germany, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.